Years of Potential Life Lost and Indirect Costs of Melanoma and Non-Melanoma Skin Cancer: A Systematic Review of the Literature

Author： GuyJr Gery P. Ekwueme Donatus U.

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.10, 2011-10, pp. : 863-874

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Photodynamic Therapy for Non-Melanoma Skin Cancer

By Fien Sari M. Oseroff Allan R.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 5, 2007-05 ,pp. : 531-540

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Quality of Life in Non-Melanoma Skin Cancer—The Skin Cancer Quality of Life (SCQoL) Questionnaire

By Vinding Gabrielle Randskov Christensen Karl Bang Esmann Solveig Olesen Anne Braae Jemec Gregor B. E.

Dermatologic Surgery, Vol. 39, Iss. 12, 2013-12 ,pp. : 1784-1793

Elsevier

Access to resources Recommend Favorite

Total body topical 5-fluorouracil for extensive non-melanoma skin cancer

By Ruth Serge Jansman Frank Sanders Cornelis

Pharmacy World and Science, Vol. 28, Iss. 3, 2006-06 ,pp. : 159-162

Springer Publishing Company

Access to resources Recommend Favorite

Health Economic Evaluation of Non-Melanoma Skin Cancer and Actinic Keratosis

By Higashi M.K.

PharmacoEconomics, Vol. 22, Iss. 2, 2004-01 ,pp. : 83-94

Adis International

Access to resources Recommend Favorite

New Perspectives in the Pharmacological Treatment of Non-Melanoma Skin Cancer

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 353-374

Bentham Science Publishers

Access to resources Recommend Favorite